May 11, 2026 03:37 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big defence boost: India successfully tests advanced Agni MIRV missile | India, Singapore unite for tough action against terror and transnational crime | TVK crosses majority mark with VCK, IUML support | I bow before Bengal: PM Modi’s powerful gesture at Suvendu Adhikari’s oath goes viral | Bengal turns a new page: Suvendu Adhikari takes oath as CM amid massive NDA show of strength | Cloud over Tamil Nadu government formation as Governor asks Vijay to prove majority | 1 Year of Operation Sindoor: PM Modi says it showed India’s firm response to terror | ‘Larger conspiracy ahead of PM Modi’s visit’: BJP on killing of Suvendu Adhikari’s aide | ‘My car was on OLX for sale’: Siliguri owner says number plate used in Suvendu aide assassination may have been cloned online | ‘Pre-planned political assassination’: BJP’s Swapan Dasgupta on Suvendu aide’s killing

Sun Pharma announces divestment of US manufacturing units

| | Jun 05, 2016, at 05:25 am
Mumbai, June 4 (IBNS): Sun Pharma on Saturday announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharm, Inc. for divestment of its two oral solid dosage manufacturing facilities located at Philadelphia, PA, and Aurora, IL both in the US, along with 15 related pharmaceutical products.

"In connection with the transaction, Frontida has agreed to continue manufacturing certain products for Sun Pharma at these facilities on a contract basis for a predetermined period. It has also agreed to offer employment to all production, quality and administrative personnel at the sites. During the divestment process, Sun Pharma was cognizant about ensuring the continued supply of quality products to patients  and protecting the interests of its employees working in these units," read a statement issued by the company.

The impact of this development on Sun Pharma’s consolidated financials and operations is not material.

Other details of the transaction are confidential. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm